Peter Zhou co-founded and leads both a venture firm (Triatomic) and a fundamental long/short hybrid hedge fund (Hongkou Capital), giving him an uncommon combination of public-markets hedge fund experience and early-stage venture investing in the same platform. He frequently leads or joins boards in highly technical, deep-tech companies like Elegen in next-generation DNA manufacturing and iPronics in reconfigurable photonics for AI data centers, reinforcing a reputation for engaging with complex, science-heavy businesses rather than just software or consumer deals. Peter Zhou co-founded and leads both a venture firm (Triatomic) and a fundamental long/short hybrid hedge fund (Hongkou Capital), giving him an uncommon combination of public-markets hedge fund experience and early-stage venture investing in the same platform. He frequently leads or joins boards in highly technical, deep-tech companies like Elegen in next-generation DNA manufacturing and iPronics in reconfigurable photonics for AI data centers, reinforcing a reputation for engaging with complex, science-heavy businesses rather than just software or consumer deals.